高端精密光学产品

Search documents
茂莱光学: 关于使用部分超募资金永久补充流动资金的公告
Zheng Quan Zhi Xing· 2025-08-13 16:24
证券代码:688502 证券简称:茂莱光学 公告编号:2025-061 南京茂莱光学科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 南京茂莱光学科技股份有限公司(以下简称"公司")于 2025 年 8 月 13 日召开公司第四届董事会第十三次会议、第四届监事会第十二次会议,审议通过 了《关于使用部分超募资金永久补充流动资金的议案》,在保证募集资金投资项 目建设的资金需求和募投项目正常进行的前提下,同意将部分超募资金人民币 保荐机构中国国际金融股份有限公司(以下简称"保荐机构")对上述事项 出具了无异议的核查意见。该事项尚需经公司股东会审议通过后方可实施,现将 相关情况公告如下: 一、募集资金基本情况 根据中国证券监督管理委员会于 2023 年 1 月 12 日出具的《关于同意南京茂 莱光学科技股份有限公司首次公开发行股票注册的批复》(证监许可〔2023〕84 号),并经上海证券交易所同意,公司获准向社会公开发行人民币普通股 1,320 万股,每股发行价格为人民币 69.72 元,募集资金总额为人民币 92 ...
茂莱光学: 中国国际金融股份有限公司关于南京茂莱光学科技股份有限公司使用部分超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-13 16:11
Group 1 - The company plans to use part of the excess raised funds, amounting to RMB 12,300.00 million, to permanently supplement its working capital, which accounts for 29.90% of the total excess funds raised [5][7][8] - The total amount of excess funds raised by the company is RMB 41,134.18 million, with a remaining balance of RMB 15,270.51 million as of June 30, 2025 [8] - The company has committed to not exceeding 30% of the total excess funds for permanent working capital supplementation within the last 12 months [8] Group 2 - The company has received approval from its board of directors and supervisory board for the use of excess funds, which will be submitted for shareholder meeting approval [7][9] - The use of excess funds is aimed at meeting the company's working capital needs, improving the efficiency of fund utilization, and reducing financial costs [8][9] - The company assures that there will be no change in the purpose of the raised funds and that it will not affect the normal progress of the investment projects [8][9]
茂莱光学: 关于部分募集资金账户注销的公告
Zheng Quan Zhi Xing· 2025-07-11 16:17
Fundraising Overview - The company, Nanjing Maolai Optical Technology Co., Ltd., successfully completed its initial public offering (IPO) by issuing 13.2 million shares at a price of RMB 69.72 per share, raising a total of RMB 920.304 million, with a net amount of RMB 811.342 million after deducting issuance costs [1][2]. Fund Management and Usage - The raised funds have been fully deposited and managed in a dedicated account as per the regulations set forth by relevant laws and guidelines, including the Company Law and Securities Law of the People's Republic of China [2][3]. - The company has established a fundraising management system to ensure proper storage, usage, and oversight of the funds, which includes signing tripartite or quadripartite supervision agreements with banks and sponsors [3][4]. Account Closure - The company has completed the closure of certain fundraising accounts as the projects funded by these accounts, namely the "High-end Precision Optical Product Production Project" and "High-end Precision Optical Product R&D Project," reached their intended usable state by June 2025 [4][5]. - The accounts at Bank of China and China Merchants Bank, which contained surplus funds, have been closed following the full utilization of the funds [5][6]. - As of the announcement date, the company has finalized the closure of the fundraising accounts and terminated the corresponding supervision agreements with the banks and sponsors [6][7].